ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 93

An HLA-C Amino Acid Variant in Addition to HLA-B*27 Confers Risk for Ankylosing Spondylitis in the Korean Population

Kwangwoo Kim1, So-Young Bang2, Seunghun Lee3, Hye-Soon Lee2, Seung-Cheol Shim4, Young Mo Kang5, Chang-Hee Suh6, Celi Sun7, Swapan Nath7, Sang-Cheol Bae2 and Tae-Hwan Kim2, 1Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 2Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 3Department of Radiology, Hanyang University College of Medicine, Seoul Hospital, Seoul, South Korea, 4Division of Rheumatology, Daejeon Rheumatoid and Degenerative Arthritis Center, Chungnam National University, Daejeon, South Korea, 5Dept of Internal Medicine, Kyungpook National University School of Medicine, Daegu, South Korea, 6Allergy-Rheumatology, Ajou University School of Medicine, Suwon, South Korea, 7Oklahoma Medical Research Foundation, Oklahoma City, OK

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Ankylosing spondylitis (AS), genetics, human leukocyte antigens (HLA), major histocompatibility complex (MHC) and population studies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Genetics, Genomics and Proteomics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Ankylosing spondylitis (AS) is a highly heritable rheumatic disease causing chronic inflammation of axial spine, joints and various organs. The presence of HLA-B*27 is strongly associated with development of AS, explaining most of the genetic associations between AS and the major histocompatibility complex (MHC) locus on human chromosome 6. Here, we investigated residual effects outside HLA-B within the MHC region.

Methods: We obtained high-density genotyping array Immunochip data for the extended MHC locus in 3,820 unrelated Korean subjects (comprising 654 cases of AS and 3,166 controls) who were ethnically homogeneous and showed no evidence of systemic bias or potential population substructure. The patients with AS satisfied the modified New York criteria for AS diagnosis. Using the SNP2HLA script and the Korean HLA reference panel, we imputed the two- and four-digit classical alleles and amino-acid residues of HLA-A, -B, –C, –DRB1, –DPB1 and –DQB1, as well as MHC SNPs (spanning 25–35 Mb). AS associations of all markers with minor allele frequency ≥1% and imputation quality (PLINK INFO) ≥0.1 were assessed using logistic regression, adding the top ten principal components as covariates. AS associations at HLA amino-acid positions (or multiple markers) were assessed using log likelihood ratio tests (LRT).

Results: We imputed 5,658 polymorphic variations including 158 classical alleles and 663 amino-acid variants in HLA-A, -B, -C, -DRB1, -DPB1 and -DQB1, as well as 4,837 MHC SNPs. The most significant associations were identified at amino-acid positions 97 (PLRT=7.20×10−479) and 114 (PLRT=2.54×10−484) in the epitope-binding site of HLA-B, highlighting the risk effect of the HLA-B*27 allele (OR=243) and the protective effects of other classical alleles (OR≤0.67). A secondary effect was located at the leucine at amino-acid position 116 in the epitope-binding site of HLA-C (p=3.76×10−15) in a conditional logistic regression analysis adding the two amino-acid positions 97 and 114 as covariates. This residue was highly correlated with the HLA-C*15:02 allele and had a large effect in HLA-B*27-negative patients (OR=6.6; 95% CI=3.8-11.4; p=1.52×10−11). After conditioning on the three AS-associated amino-acid positions, we could not find any MHC SNPs or HLA variants associated with AS susceptibility (p>1.32×10−5).

Conclusion: We identified associations of HLA-C in addition to HLA-B with AS susceptibility in the Korean population. This updates the list of AS susceptibility loci and provides new insight into AS pathogenesis mediated by MHC class I molecules.


Disclosure: K. Kim, None; S. Y. Bang, None; S. Lee, None; H. S. Lee, None; S. C. Shim, None; Y. M. Kang, None; C. H. Suh, None; C. Sun, None; S. Nath, None; S. C. Bae, None; T. H. Kim, None.

To cite this abstract in AMA style:

Kim K, Bang SY, Lee S, Lee HS, Shim SC, Kang YM, Suh CH, Sun C, Nath S, Bae SC, Kim TH. An HLA-C Amino Acid Variant in Addition to HLA-B*27 Confers Risk for Ankylosing Spondylitis in the Korean Population [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/an-hla-c-amino-acid-variant-in-addition-to-hla-b27-confers-risk-for-ankylosing-spondylitis-in-the-korean-population/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/an-hla-c-amino-acid-variant-in-addition-to-hla-b27-confers-risk-for-ankylosing-spondylitis-in-the-korean-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology